Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07166913 · ClinicalTrials.gov registry record · NA
Enhancing Engagement of Partners in Research
A NA study of Stakeholder Engagement, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 480
- Enrollment target
- 1
- Study location
NCT07166913: Recruiting NA study of Stakeholder Engagement, sponsored by NYU Langone Health.
NCT07166913 is a NA study of Stakeholder Engagement that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 480 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07166913, a NA study of Stakeholder Engagement, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 480 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the implementation and effectiveness of a bundle of engagement strategies for pediatric patient centered outcomes research (PCOR) studies. The study aims to examine the effectiveness of a "bundle" of enhanced engagement strategies on improved stakeholder engagement and study protocol indicators (including improved language access, meeting recruitment/retention goals) compared to standard practice.
Primary Outcome
This tool consists of 32 items and assesses engagement across 8 domains, using a 5-point Likert scale for each item. The 8 domains include: 1) focus on community perspectives and determinants of health, 2) partner input, 3) partnership sustainability, 4) fostering co-learning, capacity building and co-benefit, 5) building on strengths and resources, 6) facilitating collaborative, equitable partnerships, 7) involving partners in the dissemination process, and 8) building and maintaining trust. En
Conditions Studied
Interventions
- BEHAVIORAL Toolkit
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2025-09-08 |
| Est. Completion | 2026-12-01 |
| Phase | NA |
What NCT07166913 shows while recruiting
NCT07166913 is an interventional study that assigns participants to a tested intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Stakeholder Engagement appearing as the primary indexed condition, and to 1 intervention - of which Toolkit is the first listed.
NCT07166913 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07166913 about?
NCT07166913 is a clinical study titled "Enhancing Engagement of Partners in Research". The purpose of this study is to examine the implementation and effectiveness of a bundle of engagement strategies for pediatric patient centered outcomes research (PCOR) studies. The study aims to examine the effectiveness of a "bundle" of enhanced engagement strategies on improved stakeholder engag...
What is the current status of trial NCT07166913?
This trial is currently recruiting. It is a NA study. The enrollment target is 480 participants. The study started on 2025-09-08. Estimated completion is 2026-12-01.
What conditions does trial NCT07166913 study?
This clinical trial studies the following conditions: Stakeholder Engagement.
What interventions are being tested in trial NCT07166913?
The interventions under investigation include: Toolkit (BEHAVIORAL).
Who is sponsoring clinical trial NCT07166913?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07166913 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07166913's enrollment target sits among peer trials
480 216th of 2000 higher than 1,783 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01954992 · 480 participants · Phase 3
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- NCT03023696 · 480 participants · NA
Can Prophylactic Foraminotomy Prevent C5 Palsy
- NCT04948060 · 480 participants · NA
Tribally Engaged Approaches to Lung Screening (TEALS)
- NCT05053230 · 480 participants · NA
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI